SK286266B6 - Stabilný kvapalinový prípravok, spôsob jeho prípravy a jeho použitie - Google Patents

Stabilný kvapalinový prípravok, spôsob jeho prípravy a jeho použitie Download PDF

Info

Publication number
SK286266B6
SK286266B6 SK539-2002A SK5392002A SK286266B6 SK 286266 B6 SK286266 B6 SK 286266B6 SK 5392002 A SK5392002 A SK 5392002A SK 286266 B6 SK286266 B6 SK 286266B6
Authority
SK
Slovakia
Prior art keywords
sodium
liquid formulation
stable liquid
potassium salt
polyethylene glycol
Prior art date
Application number
SK539-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK5392002A3 (en
Inventor
Mikael Br�Lls
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK5392002A3 publication Critical patent/SK5392002A3/sk
Publication of SK286266B6 publication Critical patent/SK286266B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK539-2002A 1999-10-22 2000-10-13 Stabilný kvapalinový prípravok, spôsob jeho prípravy a jeho použitie SK286266B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (2)

Publication Number Publication Date
SK5392002A3 SK5392002A3 (en) 2002-10-08
SK286266B6 true SK286266B6 (sk) 2008-06-06

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
SK539-2002A SK286266B6 (sk) 1999-10-22 2000-10-13 Stabilný kvapalinový prípravok, spôsob jeho prípravy a jeho použitie

Country Status (36)

Country Link
US (1) US6730685B1 (zh)
EP (1) EP1274427B1 (zh)
JP (1) JP2003512327A (zh)
KR (1) KR100785603B1 (zh)
CN (1) CN1213751C (zh)
AR (1) AR029005A1 (zh)
AT (1) ATE304851T1 (zh)
AU (1) AU782866B2 (zh)
BG (1) BG65580B1 (zh)
BR (1) BR0014895A (zh)
CA (1) CA2425199C (zh)
CO (1) CO5261533A1 (zh)
CY (1) CY1106055T1 (zh)
CZ (1) CZ20021375A3 (zh)
DE (1) DE60022789T2 (zh)
DK (1) DK1274427T3 (zh)
EE (1) EE05175B1 (zh)
ES (1) ES2246903T3 (zh)
HK (1) HK1051142A1 (zh)
HU (1) HUP0203121A3 (zh)
IL (2) IL149107A0 (zh)
IS (1) IS2196B (zh)
MX (1) MXPA02003900A (zh)
MY (1) MY131971A (zh)
NO (1) NO329545B1 (zh)
NZ (1) NZ518155A (zh)
PL (1) PL199868B1 (zh)
RU (1) RU2286782C2 (zh)
SE (1) SE9903831D0 (zh)
SI (1) SI1274427T1 (zh)
SK (1) SK286266B6 (zh)
TR (1) TR200201103T2 (zh)
TW (1) TWI236372B (zh)
UA (1) UA74347C2 (zh)
WO (1) WO2001028558A1 (zh)
ZA (1) ZA200202905B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012225A1 (fr) * 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CN100558726C (zh) * 2003-02-24 2009-11-11 田边三菱制药株式会社 泰妥拉唑的对映体及其在治疗中的应用
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
US20090111856A1 (en) * 2006-05-09 2009-04-30 Mikael Brulls Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
EP3218510B1 (en) 2014-11-13 2019-01-02 3M Innovative Properties Company Kit comprising atp-diphosphohydrolase for detecting bacterial atp in a sample
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR930000861B1 (ko) 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
SK279554B6 (sk) 1992-07-28 1998-12-02 Astra Aktiebolag Jeho analógy
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
NO20021860D0 (no) 2002-04-19
CY1106055T1 (el) 2011-04-06
CA2425199A1 (en) 2001-04-26
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
BG106602A (en) 2002-12-29
KR100785603B1 (ko) 2007-12-14
AU782866B2 (en) 2005-09-01
ZA200202905B (en) 2003-07-14
JP2003512327A (ja) 2003-04-02
WO2001028558A1 (en) 2001-04-26
MXPA02003900A (es) 2002-09-30
MY131971A (en) 2007-09-28
IS6347A (is) 2002-04-17
IL149107A (en) 2008-04-13
SI1274427T1 (sl) 2006-02-28
EE05175B1 (et) 2009-06-15
CN1213751C (zh) 2005-08-10
HUP0203121A2 (hu) 2003-01-28
KR20020059637A (ko) 2002-07-13
CN1382048A (zh) 2002-11-27
SK5392002A3 (en) 2002-10-08
HUP0203121A3 (en) 2004-01-28
TR200201103T2 (tr) 2002-08-21
NO20021860L (no) 2002-05-21
PL199868B1 (pl) 2008-11-28
DK1274427T3 (da) 2005-12-27
NO329545B1 (no) 2010-11-08
CZ20021375A3 (cs) 2002-09-11
AU1182301A (en) 2001-04-30
HK1051142A1 (en) 2003-07-25
TWI236372B (en) 2005-07-21
EP1274427A1 (en) 2003-01-15
CA2425199C (en) 2010-12-07
UA74347C2 (uk) 2005-12-15
EE200200204A (et) 2003-04-15
BG65580B1 (bg) 2009-01-30
ES2246903T3 (es) 2006-03-01
IS2196B (is) 2007-01-15
ATE304851T1 (de) 2005-10-15
SE9903831D0 (sv) 1999-10-22
NZ518155A (en) 2004-07-30
US6730685B1 (en) 2004-05-04
AR029005A1 (es) 2003-06-04
EP1274427B1 (en) 2005-09-21
PL354926A1 (en) 2004-03-22
CO5261533A1 (es) 2003-03-31
BR0014895A (pt) 2002-06-18
RU2286782C2 (ru) 2006-11-10
IL149107A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
SK286266B6 (sk) Stabilný kvapalinový prípravok, spôsob jeho prípravy a jeho použitie
RU2126252C1 (ru) Препарат для инъекций и набор для инъекций, содержащие омепразол и его аналоги
DE60132108T2 (de) Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion
HUT70565A (en) Pharmaceutical composition containing a benzimidazole derivative having antiulcer activity
KR20010103566A (ko) 양성자 펌프 억제제의 프로드러그
ZA200100560B (en) Prodrugs of proton pump inhibitors.
SK285105B6 (sk) Dihydrát pantoprazolu horečnatého, farmaceutický prostriedok s jeho obsahom a jeho použitie
ES2222754T3 (es) Procedimiento quimico mejorado, y formulacion farmaceutica.
WO2005070426A1 (en) Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
SK282353B6 (sk) Farmaceutický prostriedok na intravenózne podanie
PT1713476E (pt) Processo para a preparação de benzimidazoles
CN101492459B (zh) 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101492462B (zh) 含有异噁唑并吡啶的苯并咪唑衍生物
CN101497623B (zh) 含有咪唑并吡啶的化合物
CN101497616B (zh) 含有氨基氧基取代的吡啶的咪唑并吡啶的化合物
CN101497603A (zh) 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121013